Functional amyloids signal their arrival

Science Signaling

Volumn 2, Issue 80, 2009, Pages

  Badtke, Matthew P ^a   Hammer, Neal D ^a   Chapman, Matthew R ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; PEPTIDE HORMONE;

ANIMAL EXPERIMENT; CYTOLOGY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SECRETORY GRANULE; SHORT SURVEY; ANIMAL; HUMAN; METABOLISM; PROTEIN FOLDING; REVIEW; SECRETORY VESICLE;

MAMMALIA; MUS; RATTUS;

AMYLOID; ANIMALS; HUMANS; MICE; PEPTIDE HORMONES; PROTEIN FOLDING; RATS; SECRETORY VESICLES;

EID: 70349575077     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.280pe43     Document Type: Short Survey

References (37)

1. D. Otzen, P. H. Nielsen, We find them here, we find them there: Functional bacterial amyloid. Cell. Mol. Life Sci. 65, 910-927 (2008).
2. J. D. Sipe, A. S. Cohen, Review: History of the amyloid fibril. J. Struct. Biol. 130, 88-98 (2000).
3. J. Ghiso, B. Frangione, Amyloidosis and Alzheimer's disease. Adv. Drug Deliv. Rev. 54, 1539-1551 (2002).
4. F. Chiti, P. Webster, N. Taddei, A. Clark, M. Stefani, G. Ramponi, C. M. Dobson, Designing conditions for in vitro formation of amyloid protofilaments and fibrils, Proc. Natl. Acad. Sci. U.S.A. 96, 3590-3594 (1999).
5. G. B. Irvine, O. M. El-Agnaf, G. M. Shankar, D. M. Walsh, Protein aggregation in the brain: The molecular basis for Alzheimer's and Parkinson's diseases. Mol. Med. 14, 451-464 (2008).
6. N. D. Hammer, X. Wang, B. A. McGuffie, M. R. Chapman, Amyloids: Friend or foe? J. Alzheimers Dis. 13, 407-419 (2008).
7. D. M. Fowler, A. V. Koulov, W. E. Balch, J.W. Kelly, Functional amyloid-from bacteria to humans. Trends Biochem. Sci. 32, 217-224 (2007).
8. H. L. True, S. L. Lindquist, A yeast prion provides a mechanism for genetic variation and phenotypic diversity.Nature 407, 477-483 (2000).
9. M. R. Chapman, L. S. Robinson, J. S. Pinkner, R. Roth, J. Heuser, M. Hammar, S. Normark, S. J. Hultgren, Role of Escherichia coli curli operons in directing amyloid fiber formation. Science 295, 851-855 (2002).
10. D. M. Fowler, A. V. Koulov, C. Alory-Jost, M. S. Marks, W. E. Balch, J. W. Kelly, Functional amyloid formation within mammalian tissue. PLoS Biol. 4, e6 (2006).
11. M. M. Barnhart, M. R. Chapman, Curli biogenesis and function. Annu. Rev. Microbiol. 60, 131-147 (2006).
12. O. Vidal, R. Longin, C. Prigent-Combaret, C. Dorel, M. Hooreman, P. Lejeune, Isolation of an Escherichia coli K-12 mutant strain able to form biofilms on inert surfaces: Involvement of a new ompR allele that increases curli expression. J. Bacteriol. 180, 2442-2449 (1998).
13. Z. Bian, A. Brauner, Y. Li, S. Normark, Expression of and cytokine activation by Escherichia coli curli fibers in human sepsis. J. Infect. Dis. 181, 602-612 (2000).
14. C. Tukel, M. Raffatellu, A. D. Humphries, R. P. Wilson, H. L. Andrews-Polymenis, T. Gull, J. F. Figueiredo, M. H. Wong, K. S. Michelsen, M. Akcelik, L. G. Adams, A. J. Baumler, CsgA is a pathogen-associated molecular pattern of Salmonella enterica serotype Typhimurium that is recognized by Toll-like receptor 2. Mol. Microbiol. 58, 289-304 (2005).
15. X. Wang, N. D. Hammer, M. R. Chapman, The molecular basis of functional bacterial amyloid polymerization and nucleation. J. Biol. Chem. 283, 21530-21539 (2008).
16. N. J. Talbot, Aerial morphogenesis: Enter the chaplins. Curr. Biol. 13, R696-R698 (2003).
17. M. A. Elliot, N. Karoonuthaisiri, J. Huang, M. J. Bibb, S. N. Cohen, C. M. Kao, M. J. Buttner, The chaplins: A family of hydrophobic cell-surface proteins involved in aerial mycelium formation in Streptomyces coelicolor. Genes Dev. 17, 1727-1740 (2003).
18. R. B. Wickner, H. K. Edskes, F. Shewmaker, T. Nakayashiki, Prions of fungi: Inherited structures and biological roles. Nat. Rev. Microbiol. 5, 611-618 (2007).
19. S. Alberti, R. Halfmann, O. King, A. Kapila, S. Lindquist, A systematic survey identifies prions and illuminates sequence features of prionogenic proteins. Cell 137, 146-158 (2009).
20. S. K. Maji, M. H. Perrin, M. R. Sawaya, S. Jessberger, K. Vadodaria, R. A. Rissman, P. S. Singru, K. P. R. Nilsson, R. Simon, D. Schubert, D. Eisenberg, J. Rivier, P. Sawchenko, W. Vale, R. Riek, Functional amyloids as natural storage of peptide hormones in pituitary secretory granules. Science 325, 328-332 (2009).
21. P. S. Dannies, Protein hormone storage in secretory granules: Mechanisms for concentration and sorting. Endocr. Rev. 20, 3-21 (1999).
22. C. Keeler, M. E. Hodsdon, P. S. Dannies, Is there structural specificity in the reversible protein aggregates that are stored in secretory granules? J. Mol. Neurosci. 22, 43-49 (2004).
23. V. H. Finder, R. Glockshuber, Amyloid-beta aggregation. Neurodegener. Dis. 4, 13-27 (2007).
24. R. Kayed, E. Head, F. Sarsoza, T. Saing, C. W. Cotman, M. Necula, L. Margol, J. Wu, L. Breydo, J. L. Thompson, S. Rasool, T. Gurlo, P. Butler, C. G. Glabe, Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers. Mol. Neurodegener. 2, 18 (2007).
25. D. J. Selkoe, Cell biology of protein misfolding: The examples of Alzheimer's and Parkinson's diseases.Nat. Cell Biol. 6, 1054-1061 (2004).
26. L. Marzban, K. Park, C. B. Verchere, Exp. Gerontol. 38, 347-351 (2003).
27. C. Korth, B. C. May, F. E. Cohen, S. B. Prusiner, Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease. Proc. Natl. Acad. Sci. U.S.A. 98, 9836-9841 (2001).
28. H. P. Moore, B. Gumbiner, R. B. Kelly, Chloroquine diverts ACTH from a regulated to a constitutive secretory pathway in AtT-20 cells. Nature 302, 434-436 (1983).
29. F. Yang, G. P. Lim, A. N. Begum, O. J. Ubeda, M. R. Simmons, S. S. Ambegaokar, P. P. Chen, R. Kayed, C. G. Glabe, S. A. Frautschy, G. M. Cole, Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J. Biol. Chem. 280, 5892-5901 (2005).
30. E. A. Epstein, M. R. Chapman, Polymerizing the fibre between bacteria and host cells: The biogenesis of functional amyloid fibres. Cell. Microbiol. 10, 1413-1420 (2008).
31. D. Destoumieux-Garzon, X. Thomas, M. Santamaria, C. Goulard, M. Barthelemy, B. Boscher, Y. Bessin, G. Molle, A. M. Pons, L. Letellier, J. Peduzzi, S. Rebuffat, Microcin E492 antibacterial activity: Evidence for a TonB-dependent inner membrane permeabilization on Escherichia coli. Mol. Microbiol. 49, 1031-1041 (2003).
32. D. Claessen, R. Rink, W. de Jong, J. Siebring, P. de Vreugd, F. G. Boersma, L. Dijkhuizen, H. A. Wosten, A novel class of secreted hydrophobic proteins is involved in aerial hyphae formation in Streptomyces coelicolor by forming amyloid-like fibrils. Genes Dev. 17, 1714-1726 (2003).
33. J. Oh, J. G. Kim, E. Jeon, C. H.Yoo, J. S. Moon, S. Rhee, I. Hwang, Amyloidogenesis of type III-dependent harpins from plant pathogenic bacteria. J. Biol. Chem. 282, 13601-13609 (2007).
34. U. Baxa, N. Cheng, D. C. Winkler, T. K. Chiu, D. R. Davies, D. Sharma, H. Inouye, D. A. Kirschner, R. B. Wickner, A. C. Steven, Filaments of the Ure2p prion protein have a cross-beta core structure. J. Struct. Biol. 150, 170-179 (2005).
35. H. A. Wosten, M. L. de Vocht, Hydrophobins, the fungal coat unravelled. Biochim. Biophys. Acta 1469, 79-86 (2000).
36. V. Coustou, C. Deleu, S. Saupe, J. Begueret, The protein product of the het-s heterokaryon incompatibility gene of the fungus Podospora anserina behaves as a prion analog. Proc. Natl. Acad. Sci. U.S.A. 94, 9773-9778 (1997).
37. K. Si, S. Lindquist, E. R. Kandel, A neuronal isoform of the aplysia CPEB has prion-like properties. Cell 115, 879-891 (2003).